1414036
Methotrexate Related Compound C
United States Pharmacopeia (USP) Reference Standard
Manufacturer: Sigma Aldrich
CAS Number: 2410-93-7
Synonym(S): Methopterine, N10-Methylfolic acid
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 50 MG | 1414036-50-MG | In Stock | ₹ 1,43,156.70 |
1414036 - 50 MG
In Stock
Quantity
1
Base Price: ₹ 1,43,156.70
GST (18%): ₹ 25,768.206
Total Price: ₹ 1,68,924.906
grade
pharmaceutical primary standard
API family
methotrexate
manufacturer/tradename
USP
application(s)
pharmaceutical (small molecule)
format
neat
storage temp.
−20°C
InChI
1S/C20H21N7O6/c1-27(9-11-8-22-16-15(23-11)18(31)26-20(21)25-16)12-4-2-10(3-5-12)17(30)24-13(19(32)33)6-7-14(28)29/h2-5,8,13H,6-7,9H2,1H3,(H,24,30)(H,28,29)(H,32,33)(H3,21,22,25,26,31)
InChI key
HLIXOCXUWGDBNP-UHFFFAOYSA-N
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
 | Sigma Aldrich Fine Chemicals Biosciences Methotrexate impurity C European Pharmacopoeia (EP) Reference Standard | 2410-93-7 | | Sigma Aldrich Fine Chemicals Biosciences | ₹ 23,582.90 | |
 | Sigma Aldrich Fine Chemicals Biosciences Methotrexate Related Compound C United States Pharmacopeia (USP) Reference Standard | 2410-93-7 | 50MG | Sigma Aldrich Fine Chemicals Biosciences | ₹ 1,51,509.65 | |
 | Methotrexate impurity C | Sigma Aldrich | ₹ 16,516.80 | |
 | 2410-93-7 | (S)-2-(4-(((2-Amino-4-oxo-3,4-dihydropteridin-6-yl)methyl)(methyl)amino)benzamido)pentanedioic acid | A2B Chem | ₹ 95,228.28 |
Related Products
Description
- General description: This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.
- Application: Methotrexate Related Compound C USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia.
- Analysis Note: These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.
- Other Notes: Sales restrictions may apply.
SAFETY INFORMATION
Pictograms
Signal Word
Danger
Hazard Statements
Precautionary Statements
P202 - P264 - P280 - P301 + P310 - P302 + P352 - P305 + P351 + P338
Hazard Classifications
Acute Tox. 3 Oral - Eye Irrit. 2 - Muta. 2 - Repr. 1B - Skin Irrit. 2
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Compare Similar Items
Show Difference
grade: pharmaceutical primary standard
API family: methotrexate
manufacturer/tradename: USP
application(s): pharmaceutical (small molecule)
format: neat
storage temp.: −20°C
InChI: 1S/C20H21N7O6/c1-27(9-11-8-22-16-15(23-11)18(31)26-20(21)25-16)12-4-2-10(3-5-12)17(30)24-13(19(32)33)6-7-14(28)29/h2-5,8,13H,6-7,9H2,1H3,(H,24,30)(H,28,29)(H,32,33)(H3,21,22,25,26,31)
InChI key: HLIXOCXUWGDBNP-UHFFFAOYSA-N
grade:
pharmaceutical primary standard
API family:
methotrexate
manufacturer/tradename:
USP
application(s):
pharmaceutical (small molecule)
format:
neat
storage temp.:
−20°C
InChI:
1S/C20H21N7O6/c1-27(9-11-8-22-16-15(23-11)18(31)26-20(21)25-16)12-4-2-10(3-5-12)17(30)24-13(19(32)33)6-7-14(28)29/h2-5,8,13H,6-7,9H2,1H3,(H,24,30)(H,28,29)(H,32,33)(H3,21,22,25,26,31)
InChI key:
HLIXOCXUWGDBNP-UHFFFAOYSA-N
grade: pharmaceutical primary standard
API family: methotrexate
manufacturer/tradename: USP
application(s): pharmaceutical (small molecule)
format: neat
storage temp.: −20°C
InChI: 1S/2C15H15N7O2.ClH/c2*1-22(10-4-2-8(3-5-10)14(23)24)7-9-6-18-13-11(19-9)12(16)20-15(17)21-13;/h2*2-6H,7H2,1H3,(H,23,24)(H4,16,17,18,20,21);1H
InChI key: WWFYKUISNIJHNQ-UHFFFAOYSA-N
grade:
pharmaceutical primary standard
API family:
methotrexate
manufacturer/tradename:
USP
application(s):
pharmaceutical (small molecule)
format:
neat
storage temp.:
−20°C
InChI:
1S/2C15H15N7O2.ClH/c2*1-22(10-4-2-8(3-5-10)14(23)24)7-9-6-18-13-11(19-9)12(16)20-15(17)21-13;/h2*2-6H,7H2,1H3,(H,23,24)(H4,16,17,18,20,21);1H
InChI key:
WWFYKUISNIJHNQ-UHFFFAOYSA-N
grade: __
API family: __
manufacturer/tradename: __
application(s): __
format: __
storage temp.: __
InChI: 1S/C9H5Cl2N/c10-6-1-2-7-8(11)3-4-12-9(7)5-6/h1-5H
InChI key: HXEWMTXDBOQQKO-UHFFFAOYSA-N
grade:
__
API family:
__
manufacturer/tradename:
__
application(s):
__
format:
__
storage temp.:
__
InChI:
1S/C9H5Cl2N/c10-6-1-2-7-8(11)3-4-12-9(7)5-6/h1-5H
InChI key:
HXEWMTXDBOQQKO-UHFFFAOYSA-N
grade: pharmaceutical primary standard
API family: levomepromazine
manufacturer/tradename: USP
application(s): pharmaceutical (small molecule)
format: neat
storage temp.: __
InChI: 1S/C19H24N2OS/c1-14(12-20(2)3)13-21-16-7-5-6-8-18(16)23-19-10-9-15(22-4)11-17(19)21/h5-11,14H,12-13H2,1-4H3/t14-/m1/s1
InChI key: VRQVVMDWGGWHTJ-CQSZACIVSA-N
grade:
pharmaceutical primary standard
API family:
levomepromazine
manufacturer/tradename:
USP
application(s):
pharmaceutical (small molecule)
format:
neat
storage temp.:
__
InChI:
1S/C19H24N2OS/c1-14(12-20(2)3)13-21-16-7-5-6-8-18(16)23-19-10-9-15(22-4)11-17(19)21/h5-11,14H,12-13H2,1-4H3/t14-/m1/s1
InChI key:
VRQVVMDWGGWHTJ-CQSZACIVSA-N